Top

European Archives of Oto-Rhino-Laryngology

Published in:

01-03-2017 | Head and Neck

Thyroid autoimmunity: is really associated with papillary thyroid carcinoma?

Authors: Alev Selek, Berrin Cetinarslan, Ilhan Tarkun, Zeynep Canturk, Berna Ustuner, Zeynep Akyay

Published in: European Archives of Oto-Rhino-Laryngology | Issue 3/2017

Abstract

The incidence of thyroid cancer has been greatly increasing. Several studies aimed to investigate biomarkers for prediction of thyroid cancer. Some of these studies have suggested that thyroid autoantibodies (TAb) could be used as predictors of thyroid cancer risk, but the correlation between TAb and PTC is still a matter of debate. The aim of this study is to evaluate thyroid autoimmunity and TAbs in patients with PTC and benign multinodular goiter (MNG) to investigate if TAbs and autoimmune thyroid disease (ATD) could predict thyroid malignancy. A total of 577 patients with thyroid papillary carcinoma (PTC) and 293 patients with benign MNG disease were enrolled postoperatively. Demographic features, thyroglobulin (TgAb) and thyroid peroxidase antibodies (TPOAb) and histologic outcome of the patients were evaluated. The prevalence of ATD and TgAb or TPOAb measurements was not statistically different in PTC and MNG groups. However, tumors were significantly smaller and tumor capsule invasion was seen less frequently in patients with PTC and ATD than without ATD. Patients without ATD had more advanced stage (TNM stage III/IV) tumors than with ATD. Only one of the 11 patients with distant organ metastasis had ATD. The present study demonstrated that the prevalence of ATD diagnosed even with histology or TAb positivity was not different in patients with PTC and MNG. However, having ATD might be associated with a better prognosis in PTC patients.

Pellegriti G, Frasca F, Regalbuto C et al (2013) Worldwide increasing incidence of thyroid cancer: update on epidemiology and risk factors. J Cancer Epidemiol 2013:965212 (Epub 7 May 2013) CrossRefPubMedPubMedCentral

Verkooijen HM, Fioretta G, Pache JC et al (2003) Diagnostic changes as a reason for the increase in papillary thyroid cancer incidence in Geneva, Switzerland. Cancer Causes Control 14(1):13–17CrossRefPubMed

Kim ES, Lim DJ, Baek KH et al (2010) Thyroglobulin antibody is associated with increased cancer risk in thyroid nodules. Thyroid 20(8):885–891CrossRefPubMed

Fiore E, Rago T, Latrofa F et al (2011) Hashimoto’s thyroiditis is associated with papillary thyroid carcinoma: role of TSH and of treatment with l-thyroxine. Endocr Relat Cancer 18(4):429–437CrossRefPubMed

Caturegli P, De Remigis A, Chuang K et al (2013) Hashimoto’s thyroiditis: celebrating the centennial through the lens of the Johns Hopkins hospital surgical pathology records. Thyroid 23(2):142–150CrossRefPubMedPubMedCentral

Chen YK, Lin CL, Cheng FT et al (2013) Cancer risk in patients with Hashimoto’s thyroiditis: a nationwide cohort study. Br J Cancer 109(9):2496–2501CrossRefPubMedPubMedCentral

Cunha LL, Morari EC, Guihen AC et al (2012) Infiltration of a mixture of immune cells may be related to good prognosis in patients with differentiated thyroid carcinoma. Clin Endocrinol (Oxf) 77(6):918–925CrossRef

French JD, Kotnis GR, Said SJ et al (2012) Programmed death-1+ T cells and regulatory T cells are enriched in tumor-involved lymph nodes and associated with aggressive features in papillary thyroid cancer. J Clin Endocrinol Metab 97(6):E934–E943CrossRefPubMedPubMedCentral

Qing W, Fang WY, Ye L et al (2012) Density of tumor associated macrophages correlates with lymph node metastasis in papillary thyroid carcinoma. Thyroid 22(9):905–910CrossRefPubMedPubMedCentral

10.

Xu WC, Li ZB, Chen YR et al (2011) Expression and distribution of S-100, CD83, and costimulatory molecules (CD80 and CD86) in tissues of thyroid papillary carcinoma. Cancer Invest 29(4):286–292CrossRefPubMed

11.

Yu H, Huang X, Liu X et al (2013) Regulatory T cells and plasmacytoid dendritic cells contribute to the immune escape of papillary thyroid cancer coexisting with multinodular non-toxic goiter. Endocrine 44(1):172–181CrossRefPubMed

12.

Wu X, Lun Y, Jiang H et al (2014) Coexistence of thyroglobulin antibodies and thyroid peroxidase antibodies correlates with elevated thyroid-stimulating hormone level and advanced tumor stage of papillary thyroid cancer. Endocrine 46(3):554–560CrossRefPubMed

13.

Hollowell JG, Staehling NW, Flanders WD et al (2002) Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 87:489–499CrossRefPubMed

14.

Spencer CA (2011) Clinical review: clinical utility of thyroglobulin antibody (TgAb) measurements for patients with differentiated thyroid cancers (DTC). J Clin Endocrinol Metab 96:3615–3627CrossRefPubMed

15.

Edge SB, Byrd DR, Compton C et al (2010) AJCC cancer staging manual, 7th edn. Springer, New York

16.

Lun Y, Wu X, Xia Q et al (2013) Hashimoto’s thyroiditis as a risk factor of papillary thyroid cancer may improve cancer prognosis. Otolaryngol Head Neck Surg 148:396–402CrossRefPubMed

17.

Wartofsky L (2010) Increasing world incidence of thyroid cancer: increased detection or higher radiation exposure. Hormones 9(2):103–108CrossRefPubMed

18.

Ostroumova E, Brenner A, Oliynyk V et al (2009) Subclinical hypothyroidism after radioiodine exposure: Ukrainian–American cohort study of thyroid cancer and other thyroid diseases after the chornobyl accident (1998–2000). Environ Health Perspect 117(5):745–750CrossRefPubMed

19.

Gomez Segovia I, Gallowitsch HJ, Kresnik E et al (2004) Descriptive epidemiology of thyroid carcinoma in Carinthia, Austria: 1984–2001. Histopathologic features and tumor classification of 734 cases under elevated general iodination of table salt since 1990: population-based age-stratified analysis on thyroid carcinoma incidence. Thyroid 14(4):277–286CrossRef

20.

Laurberg P, Cerqueira C, Ovesen L et al (2010) Iodine intake as a determinant of thyroid disorders in populations. Best Pract Res 24(1):13–27CrossRef

21.

Bloodworth JMB, Lechago J, Gould VE (1996) Bloodworth’s endocrine pathology, 3rd edn. Williams & Wilkins, Baltimore

22.

Singh B, Shaha AR, Trivedi H et al (1999) Coexistent Hashimoto’s thyroiditis with papillary thyroid carcinoma: impact on presentation, management, and outcome. Surgery 126(6):1070–1077CrossRefPubMed

23.

Ward LS, Assumpção LV (2007) The impact of gender in differentiated thyroid cancer. Clin Endocrinol 66(5):752–753CrossRef

24.

Cunha LL, Ferreira RC, Marcello MA et al (2011) Clinical and pathological implications of concurrent autoimmune thyroid disorders and papillary thyroid cancer. J Thyroid Res 17(2011):387062

25.

Boi F, Lai ML, Marziani B et al (2005) High prevalence of suspicious cytology in thyroid nodules associated with positive thyroid autoantibodies. Eur J Endocrinol 153(5):637–642CrossRefPubMed

26.

Fiore E, Rago T, Scutari M et al (2009) Papillary thyroid cancer, although strongly associated with lymphocitic infiltration on histology, is only weakly predicted by serum thyroid autoantibodies in patients with nodular thyroid disease. J Endocrinol Invest 32(4):344–351CrossRefPubMed

27.

Boelaert K, Horacek J, Holder RL et al (2006) Serum thyrotropin concentration as a novel predictor of malignancy in thyroid nodules investigated by fine-needle aspiration. J Clin Endocrinol Metab 91(11):4295–4301CrossRefPubMed

28.

Rago T, Di Coscio G, Ugolini C et al (2007) Clinical features of thyroid autoimmunity are associated with thyroiditis on histology and are not predictive of malignancy in 570 patients with indeterminate nodules on cytology who had a thyroidectomy. Clin Endocrinol (Oxf) 67(3):363–369CrossRef

29.

Fiore E, Rago T, Provenzaleetal MA et al (2009) Lower levels of TSH are associated with a lower risk of papillary thyroid cancer in patients with thyroid nodular disease: thyroid autonomy may play a protective role. Endocr Relat Cancer 16(4):1251–1260CrossRefPubMed

30.

Jankovic B, Le KT, Hershman JM (2013) Clinical review: Hashimoto’s thyroiditis and papillary thyroid carcinoma: is there a correlation? J Clin Endocrinol Metab 98(2):474–482CrossRefPubMed

31.

Wirtschafter A, Schmidt R, Rosen D et al (1997) Expression of the RET/PTC fusion gene as a marker for papillary carcinoma in Hashimoto’s thyroiditis. Laryngoscope 107(1):95–100CrossRefPubMed

32.

Sheils OM, O’Leary JJ, Uhlmann V et al (2000) Ret/PTC-1 activation in Hashimoto thyroiditis. Int J Surg Pathol 8(3):185–189CrossRefPubMed

33.

Elisei R, Romei C, Vorontsova T et al (2001) RET/PTC rearrangements in thyroid nodules: studies in irradiated and not irradiated, malignant and benign thyroid lesions in children and adults. J Clin Endocrinol Metab 86(7):3211–3216PubMed

34.

Guarino V, Castellone MD, Avilla E et al (2010) Thyroid cancer and inflammation. Mol Cell Endocrinol 32(1):94–102CrossRef

35.

Muzza M, Degl’Innocenti D, Colombo C et al (2010) The tight relationship between papillary thyroid cancer, autoimmunity and inflammation: clinical and molecular studies. Clin Endocrinol 72(5):702–708CrossRef

36.

Kashima K, Yokoyama S, Noguchi S et al (1998) Chronic thyroiditis as a favorable prognostic factor in papillary thyroid carcinoma. Thyroid 8(3):197–202CrossRefPubMed

37.

Loh KC, Greenspan FS, Dong F et al (1999) Influence of lymphocytic thyroiditis on the prognostic outcome of patients with papillary thyroid carcinoma. J Clin Endocrinol Metab 84(2):458–463CrossRefPubMed

38.

Kim EY, Kim WG, Kim WB et al (2009) Coexistence of chronic lymphocytic thyroiditis is associated with lower recurrence rates in patients with papillary thyroid carcinoma. Clin Endocrinol 71(4):581–586CrossRef

39.

Gupta S, Patel A, Folstad A et al (2001) Infiltration of differentiated thyroid carcinoma by proliferating lymphocytes is associated with improved disease-free survival for children and young adults. J Clin Endocrinol Metab 86(3):1346–1354PubMed

40.

Medenica S, Radojevic N, Stojkovic M et al (2015) Autoimmunity and thyrotropin level in developing thyroid malignancy. Eur Rev Med Pharmacol Sci 19(15):2824–2829PubMed

41.

Yano Y, Shibuya H, Kitagawa W et al (2007) Recent outcome of grave’s disease patients with papillary thyroid cancer. Eur J Endocrinol 157(3):325–329CrossRefPubMed

42.

Kim HS, Choi YJ, Yun JS (2010) Features of papillary thyroid microcarcinoma in the presence and absence of lymphocytic thyroiditis. Endocr Pathol 21(3):149–153CrossRefPubMed

43.

Sakorafas GH, Giotakis J, Stafyla V (2005) Papillary thyroid microcarcinoma: a surgical perspective. Cancer Treat Rev 31(6):423–438CrossRefPubMed

44.

Falvo L, D’Ercole C, Sorrenti S et al (2003) Papillary microcarcinoma of the thyroid gland: analysis of prognostic factors including histological subtype. Eur J Surg Suppl 588:28–32

Title: Thyroid autoimmunity: is really associated with papillary thyroid carcinoma?
Authors: Alev Selek
Berrin Cetinarslan
Ilhan Tarkun
Zeynep Canturk
Berna Ustuner
Zeynep Akyay
Publication date: 01-03-2017
Publisher: Springer Berlin Heidelberg
Published in: European Archives of Oto-Rhino-Laryngology / Issue 3/2017
Print ISSN: 0937-4477
Electronic ISSN: 1434-4726
DOI: https://doi.org/10.1007/s00405-016-4414-6

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Thyroid autoimmunity: is really associated with papillary thyroid carcinoma?

Abstract

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2017

Investigations on the prevalence of the photo-induced sneezing reflex in the German population, a representative cross-sectional study

Effects of mobile phone WeChat services improve adherence to corticosteroid nasal spray treatment for chronic rhinosinusitis after functional endoscopic sinus surgery: a 3-month follow-up study

Olfaction and sinonasal symptoms in patients with CRSwNP and AERD and without AERD: a cross-sectional and longitudinal study

The impact of erdosteine on cisplatin-induced ototoxicity: a proteomics approach

The comparison of the quality of life and intranasal edema between the patients with or without nasal packing after septoplasty

Chronological changes in microbial profiles in external and middle ear diseases: a 20-year study in Korea